Abstract:Porous biphasic calcium phosphate bioceramic (BCP) possesses osteoinductivity to induce the osteoblastic commitment of mesenchymal stem cells (MSCs) and ectopic bone formation. However, the underlying mechanism remains enigmatic. We performed a gene array analysis of MSCs cocultured with BCP to screen for candidate osteoinductive modulators. Na+, K+-ATPase (NKA), an ion transporter, therefore was identified as a crucial ion transporter in regulating the osteogenesis of the cells. NKA activator, a polyclonal antibody, enriched the cytomembrane abundance of NKA and lead to an enhanced osteogenic effect of BCP. As indicated in gene array analysis and suggested by co-immunoprecipitation assay, protein phosphatase 2A (PP2A) was elevated by BCP to dephosphorylate NKA and prevent its endocytosis. The inhibition of NKA by ouabain resulted in an adverse effect on osteoinductivity of BCP. We further altered NKA activity in mice implanted with BCP and found that the intensity and incidence of osteoinduction was increased by the NKA activator. We went one step further by investigating the potential of targeting NKA in osteoporotic bone regeneration. Activating NKA upregulated osteogenic gene expression and calcium deposition ability of osteoporotic osteoblasts. Furthermore, activation of NKA in mice ameliorated estrogen-deficiency induced bone loss, in terms of increased bone mass and improved bending strength. With this osteoinductive bioceramic derived ion transporter target, we demonstrate that the activation of NKA has significant potential to revolutionize the regeneration of bone. Statement of significance In this study, we identified an important role of Na+, K+-ATPase (NKA) have played in osteoinductivity of biphasic calcium phosphate bioceramic (BCP). Furthermore, we demonstrated the therapeutic potential of targeting NKA in osteoporotic bone regeneration. Numerous gene and protein targets to treat osteoporosis were discovered every year, mainly obtained by genomic and proteomic screenings of a large population. In contrast, our study identified an unrevealed bone regenerating target from the upregulated genes induced by an osteoinductive biomaterial. The approach was cost-saving since it did not require a large sample pool. Furthermore, the target derived from this approach was proven to be anabolic. Identification of an anabolic agent holds significant value since most of the current anti-osteoporotic therapies are antiresorptive. (C) 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Multiple Signaling Pathways Involved in Stimulation of Osteoblast Differentiation by N-methyl-D-aspartate Receptors Activation in Vitro

PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

Expression of Functional Metabotropic Glutamate Receptors in Primary Cultured Rat Osteoblasts: CROSS-TALK WITH N-METHYL-d-ASPARTATE RECEPTORS

NMDA enhances stretching-induced differentiation of osteoblasts through the ERK1/2 signaling pathway.

Mineralizing Solution and Dexamethasone Enhance Receptor Activator for NF-κB Ligand Expression in Rat Bone Marrow Stromal Cells

Expression of Functional Metabotropic Glutamate Receptors in Primary Cultured Rat Osteoblasts

Identification of NMDA Glutamate Receptors Expressed in Bone Precursor Cell and Osteoblasfic Cells and it's Involvement in Mechanotransduction

NMDA-induced Increases in Intracellular Ca2+ Concentrations in Osteoblasts

Involvement of MAPK Pathway in the Osteoblastic Differentiation of Mouse Mesenchymal Stem Cells

Dopamine D1 Receptor-Mediated Activation of the ERK Signaling Pathway is Involved in the Osteogenic Differentiation of Bone Mesenchymal Stem Cells

Group Ⅲ metabotropic glutamate receptors promotes primary osteoblast mineralization through OPG/RANKL pathway

AMP-activated Protein Kinase Stimulates Osteoblast Differentiation and Mineralization Through Autophagy Induction

Group III Metabotropic Glutamate Receptor Activation Inhibits Ca2+ Influx and Nitric Oxide Synthase Activity in Bone Marrow Stromal Cells

Role of Na<SUP>+</SUP>, K<SUP>+</SUP>-ATPase ion pump in osteoinduction

NMDA receptors inhibit axonal outgrowth by inactivating Akt and activating GSK-3β via calcineurin in cultured immature hippocampal neurons.

Activation of PKA and Phosphorylation of Sodium-Dependent Vitamin C Transporter 2 by Prostaglandin E2 Promote Osteoblast-Like Differentiation in MC3T3-E1 Cells.

AMN082 Promotes the Proliferation and Differentiation of Neural Progenitor Cells with Influence on Phosphorylation of MAPK Signaling Pathways

N-Methyl-D-Aspartate Attenuates Opioid Receptor-Mediated G Protein Activation and This Process Involves Protein Kinase C

Effects of nerve growth factor on the differentiation of rat bone marrow stroma cells into osteoblasts

Knockdown of NRAGE Induces Odontogenic Differentiation by Activating NF-κB Signaling in Mouse Odontoblast-Like Cells

Dopaminergic Effects on in Vitro Osteogenesis.